TOP GLOVE’S EARNINGS SURGING MORE THAN DOUBLE IN 3QFY20
CREDIT SUISSE RAISES TARGET PRICE FOR TOP GLOVE TO RM23, EXPECTS RECORD FY21
POST-COVID-19, GLOVE DEMAND TO GROW 12% A YEAR — TOP GLOVE
ON MEETING RISING DEMAND FOR MEDICAL GLOVES AND PREPARING FOR LONG-TERM INDUSTRY EXPANSION
ANALYSTS UNFAZED ABOUT US FDA'S IMPORT ALERT ON TOP GLOVE’S UNIT
THIS MALAYSIAN GLOVE MAKER IS NOW AMONG THE TOP 15 BIGGEST CAP STOCKS ON SGX
TOP GLOVE ONE OF LARGEST BENEFICIARIES OF COVID-19 PANDEMIC
TOP GLOVE’S HIGHER ASPS, DEMAND SURGE STILL UNDER-APPRECIATED
RALLY PUTS TOP GLOVE IN RUNNING FOR TOP 5 SPOT IN MALAYSIA INDEX